Table 2 Specialty of physicians who order molecular testing
From: Analysis of factors influencing molecular testing at diagnostic of colorectal cancer
KRAS (n = 445) | BRAF (n = 133) | MSI (n = 138) | |
|---|---|---|---|
Pathologists | 174 (39.1%) | 38 (28.6%) | 34 (24.6%) |
Surgeons | 105 (23.6%) | 22 (16.5%) | 21 (15.2%) |
Oncologists | 84 (18.9%) | 37 (27.8%) | 43 (31.2%) |
Gastroenterologists | 9 (2.0%) | 1 (0.7%) | 1 (0.7%) |
Others | 4 (0.9%) | 7 (5.3%) | 5 (3.6%) |
Non communicated/unknown | 69 (15.5%) | 28 (21.1%) | 34 (24.6%) |